Federal Courts Issue Conflicting Rulings in Drug Makers’ Lawsuits over 340B Requirements
- November 12, 2021
Two federal courts recently issued conflicting rulings in the ongoing dispute between pharmaceutical companies and the Department of Health and Human Services (HHS) over 340B program requirements.
ARTICLE TAGS
You must be logged in to access this content.